Cadence’s dual announcements with NVIDIA and Google mark pragmatic steps in the industry’s transition toward intelligent, ...
Government-funded academic research on parallel computing, stream processing, real-time shading languages, and programmable ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
The final version of a new National Planning Policy Framework (NPPF) is due to be published in the summer and should set a ...
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above ...
Fifth Third Bancorp ( FITB) Q1 2026 Earnings Call April 17, 2026 9:00 AM EDT Good morning. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome ...
Gloo Holdings, Inc. (NASDAQ:GLOO) Q4 2025 Earnings Call Transcript April 14, 2026 Gloo Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.78 EPS, expectations were $-0.31. Operator: ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, launched a simulator that fully leverages the unique advantages of FPGA (Field-Programmable Gate ...
Yesterday, we announced that Credo has entered into a definitive agreement to acquire DustPhotonics, a leader in Silicon Photonics PIC technology. This is a meaningful step forward for Credo. It ...
There is no more doubt left: a global famine is on the way. The impact will be monumental. The war in Iran is only the beginning of what is promising to be a sustained global crisis. Already, we are ...
Zelthy’s AI governance framework helps pharma companies manage multi-jurisdiction compliance ahead of EU AI Act 2026 rules.
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC diag ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results